Brazilian pharma industry sues regulator
This article was originally published in Scrip
Executive Summary
Interfarma, the Brazilian pharmaceutical industry association, has brought a lawsuit against the medicines regulator, ANVISA, over its role in the granting of patents for medicinal products.